AnatGe: “Universal Stereotactic Treatments”

AnatGe designs and produces medical devices in the field of oncology, specifically related to the implementation of SBRT and SRS (Stereotactic BodyRadiation Therapy & Stereotactic Radiosurgery). Our products arise from clinical practice and seek to solve its problems in an innovative manner. All incorporate new improvements and advances to existing technology, which offer clear clinical advantages and even constitute relevant changes in the manner in which treatments are applied. In order for this to be possible, in addition to being committed to innovation at our company, we are committed to training professionals involved with oncology treatment. OUR AIM AnatGe’s purpose is to convert stereotactic radiosurgery (SRS) and highoxidative stress therapy (SBRT or SABR) to conventional and universal techniques that all cancer patients can enjoy. Therefore our technologies improve efficiency and efficacy of treatments, by reducing application times and design costs of this kind of techniques. OUR COMMITMENT At AnatGe, we have a clear commitment to: - research and innovation: these are pillars of our company and what allows us to offer products that contribute value to professionals and patients. - patients: technologies that we develop reduce treatment times and toxicity while increasing their accuracy and efficiency; - quality: all our devices are marketed complying with all European Agency of Medicines and CE marking regulations.